Patent Valuation — Patent Value Assessment
Enhances the IP valuation capabilities of the ip-analyst and license-strategist agents.
Valuation Methodologies
Three Approaches
| Approach |
Method |
Best Suited For |
| Cost Approach |
Cost of development/acquisition |
Early-stage, no alternative technology |
| Market Approach |
Comparable IP transaction data |
Comparable transactions exist |
| Income Approach |
Present value of future income |
Clear monetization pathway |
Cost Approach
Reproduction Cost:
= R&D Labor + Materials + Equipment + Overhead
+ Opportunity Cost (time value)
- Depreciation (functional/economic obsolescence)
Example:
R&D Cost: $500,000
Overhead: $100,000
Obsolescence Depreciation: -20%
Value: (500,000 + 100,000) x 0.8 = $480,000
Market Approach
Comparable Transaction Comparison:
Value = Comparable IP Transaction Price x Adjustment Factor
Adjustment Factors:
- Technology similarity (0.5-1.5)
- Market size ratio
- Remaining protection period ratio
- Rights scope (exclusive/non-exclusive)
Income Approach (Relief from Royalty)
Value = Sum of [Revenue_t x Royalty Rate x (1-Tax Rate) / (1+r)^t]
t: Remaining patent term (1 to N years)
r: Discount rate (WACC basis, 12-20%)
Royalty Rate: Industry-specific benchmark (see below)
Industry Royalty Benchmarks
| Industry |
Royalty Rate Range |
Median |
| Pharmaceutical/Biotech |
3-10% |
5% |
| Semiconductor/Electronics |
1-5% |
3% |
| Software |
5-25% |
10% |
| Chemical/Materials |
2-5% |
3% |
| Machinery/Equipment |
1-5% |
3% |
| Consumer Goods |
2-8% |
4% |
| Automotive |
1-3% |
2% |
25% Rule (Rule of Thumb)
Royalty = Licensee Operating Profit x 25%
Rationale: 25% of patent-contributed profit goes to the patent holder
Caveat: Courts use this only as a reference, not an absolute standard
Patent Strength Assessment
Patent Scorecard
| Evaluation Item |
Weight |
Score (1-5) |
| Claim Scope |
20% |
Broader = higher |
| Design-Around Difficulty |
20% |
More difficult = higher |
| Technical Importance |
15% |
More critical = higher |
| Citation Frequency |
15% |
More cited = higher |
| Remaining Term |
15% |
Longer = higher |
| Market Relevance |
15% |
Greater applicability = higher |
Strength Ratings
| Total Score |
Rating |
Strategy |
| 4.0-5.0 |
A (Core) |
Active protection, licensing monetization |
| 3.0-3.9 |
B (Important) |
Retain, portfolio strengthening |
| 2.0-2.9 |
C (Moderate) |
Cost-efficiency review, sale consideration |
| 1.0-1.9 |
D (Weak) |
Abandonment/sale recommended |
License Structure Design
License Types
| Type |
Description |
Royalty Structure |
| Exclusive |
Only licensee may practice |
High upfront + royalty |
| Non-exclusive |
Multiple licensees |
Lower upfront + royalty |
| Sublicensable |
Relicensing permitted |
Royalty sharing agreement |
| Cross-license |
Mutual practice rights |
Royalty-free or balancing |
Royalty Structures
Lump-sum: One-time payment at agreement
Running Royalty: Periodic payment based on sales/volume
Minimum Royalty: Annual minimum guarantee
Milestone: Stage-based payments (development/commercialization)
Hybrid: Lump-sum + running combination
Quality Checklist
| Item |
Criteria |
| Valuation Methods |
At least 2 of the 3 approaches |
| Royalty Basis |
Industry benchmarks cited |
| Discount Rate |
Calculation basis specified |
| Patent Strength |
6-item scorecard |
| Scenarios |
Conservative/Baseline/Optimistic (3 scenarios) |
| Remaining Term |
Present value based on expiration date |